Neogen Corporation (NEOG)
Wall Street's Insights Into Key Metrics Ahead of Neogen (NEOG) Q1 Earnings
Get a deeper insight into the potential performance of Neogen (NEOG) for the quarter ended August 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
The Bottom Fishing Club - Neogen: Combine Business Turnaround With Defensive Trading History
Neogen's share price collapsed due to an expensive 2022 acquisition using excessive debt, but recent divestitures and operational improvements signal a turnaround opportunity. The company has a new CEO and is simplifying its business, paying down debt, and expecting margin recovery with projected FY 2026 revenue of $820M–$840M. Underlying technical momentum has been building all summer, with very strong numbers for the stock in August.
Neogen (NEOG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Neogen (NEOG) give insight into how the company performed in the quarter ended May 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Neogen Corporation (NEOG) Q4 2025 Earnings Call Transcript
Neogen Corporation (NASDAQ:NEOG ) Q4 2025 Earnings Conference Call July 29, 2025 8:00 AM ET Company Participants Bill Waelke - Head of Investor Relations David H. Naemura - COO & CFO John Edward Adent - President, CEO & Director Conference Call Participants Brandon Vazquez - William Blair & Company L.L.C.
Neogen (NEOG) Q4 Earnings Lag Estimates
Neogen (NEOG) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.1 per share a year ago.
Earnings Preview: Neogen (NEOG) Q4 Earnings Expected to Decline
Neogen (NEOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neogen Stock Gains Following Strategic Alliance With Syngenta
NEOG inks a new strategic licensing and supply agreement with Syngenta to market and sell the latter's Talon-G and Talon Weatherblok XT rodenticides in the United States and Canada.
Why Is Neogen (NEOG) Up 6.4% Since Last Earnings Report?
Neogen (NEOG) reported earnings 30 days ago. What's next for the stock?
Neogen: A Fair Divestment (Rating Upgrade)
Neogen's merger with 3M Food Safety led to significant debt and operational struggles, causing shares to plummet and the CEO to be ousted. Following disappointing sales and earnings, the company is exploring asset sales and restructuring, offering potential upside if stabilization occurs. Neogen's current valuation appears modest relative to sales, presenting a speculative opportunity for investors willing to take on risk.
Neogen Stock Tumbles on Q3 Earnings & Sales Miss, Margins Contract
NEOG posts lower-than-expected earnings and revenues for the third quarter of fiscal 2025.
Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Neogen (NEOG) give a sense of how the business performed in the quarter ended February 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Neogen (NEOG) Lags Q3 Earnings and Revenue Estimates
Neogen (NEOG) came out with quarterly earnings of $0.10 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.12 per share a year ago.
